Lemonade Stock Fair Value Calculator – LEMONADE Reports Q2 Earnings Results for FY 2023 on June 30th
August 27, 2023
🌥️Earnings Overview
On June 30, 2023, LEMONADE ($NYSE:LMND) reported second quarter fiscal year 2023 earnings results. Total revenue for the period was USD 99.6 million, representing a 107.9% increase from the same quarter in the previous year. Net income was USD -67.2 million, compared to a net loss of -67.9 million in the same quarter of the prior year.
Stock Price
On Friday, June 30th, LEMONADE reported its earnings results for the second quarter of fiscal year 2023. The company opened the market at $17.7 and closed with a price of $17.1, marking a decrease of 1.0% from the previous closing price of $17.3. The downward trend of the stock came as a surprise to investors in the wake of the positive outlook seen in the first quarter of this fiscal year. Despite this news, the company is expecting to continue to grow in the coming months and years, particularly in terms of its online presence.
Looking forward, LEMONADE will be focusing on developing its products and services to better serve its customers. The company aims to build on its existing success, while also introducing new innovation into the market. With a strong plan in place, LEMONADE is confident that it will deliver higher returns in the future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Lemonade. LEMONADE_Reports_Q2_Earnings_Results_for_FY_2023_on_June_30th”>More…
| Total Revenues | Net Income | Net Margin |
| 344.7 | -288.1 | -83.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Lemonade. LEMONADE_Reports_Q2_Earnings_Results_for_FY_2023_on_June_30th”>More…
| Operations | Investing | Financing |
| -180 | 172.5 | 2.9 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Lemonade. LEMONADE_Reports_Q2_Earnings_Results_for_FY_2023_on_June_30th”>More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.61k | 842.1 | 11.07 |
Key Ratios Snapshot
Some of the financial key ratios for Lemonade are shown below. LEMONADE_Reports_Q2_Earnings_Results_for_FY_2023_on_June_30th”>More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 51.9% | – | – |
| FCF Margin | ROE | ROA |
| -55.1% | -22.6% | -11.2% |
Analysis – Lemonade Stock Fair Value Calculator
At GoodWhale, we have taken a close look at the fundamentals of LEMONADE‘s stock. After running our proprietary Valuation Line, our analysis has determined that the intrinsic value of LEMONADE’s stock is approximately $132.3. This means that currently LEMONADE’s stock is being traded at $17.1, undervalued by 87.1%. This provides a great opportunity for investors to buy the stock at a significant discount to its intrinsic value. More…
Peers
In the business world, competition is key. It drives innovation and keeps prices down. This is especially true in the case of Lemonade Inc, a company that competes with Waterdrop Inc, SelectQuote Inc, and ICPEI Holdings Inc. All four companies offer similar products and services, so they must constantly strive to outdo each other. This competition is good for consumers, as it leads to better products and lower prices.
– Waterdrop Inc ($NYSE:WDH)
Waterdrop Inc is a holding company that provides financial services. It operates through its subsidiaries, which include Waterdrop Bank, Waterdrop Insurance, and Waterdrop Investments. The company was founded in 2013 and is headquartered in San Francisco, California.
– SelectQuote Inc ($NYSE:SLQT)
SelectQuote Inc is a provider of life insurance products and services in the United States. The company has a market cap of 109.85M as of 2022 and a return on equity of -55.07%. The company offers a variety of life insurance products and services, including term life, whole life, universal life, and indexed universal life insurance. It also offers annuities, long-term care insurance, and disability income insurance.
– ICPEI Holdings Inc ($TSXV:ICPH)
ICPEI Holdings Inc. engages in the provision of healthcare services. It operates through the following segments: Healthcare Services, Drug Discovery and Development, and Corporate and Other. The Healthcare Services segment includes hospitals, clinics, and other ancillary services. The Drug Discovery and Development segment focuses on the research and development of drugs. The Corporate and Other segment comprises of corporate operations and other investments. The company was founded on May 11, 2004 and is headquartered in New York, NY.
Summary
Lemonade‘s second quarter of its fiscal year 2023 was a success, with total revenue increasing by over 100%. However, the company reported a net loss of -67.2 million which was slightly lower than the -67.9 million reported in the same quarter a year ago. Investors should carefully consider the company’s long-term prospects, taking into account the potential for aggressive growth as well as current profitability. Additionally, it is important to assess how Lemonade’s financials compare to competitors in the industry and how they are expected to change in the future.
